Recipient
15138671 Canada Inc.Department
National Research Council CanadaAmount
$75.0K
Province
QCType
Contribution
Agreement Number
172-2024-2025-Q3-1023979
Purpose
The project supports the advancement of the Firm's technology to TRL 5. More specifically, this will involve the design, development, and testing of the firm’s first multi-tube reactor prototype. This project will provide critical data to validate the performance, reliability, and economic value of the system, crucial for de-risking technical and scientific challenges associated with scaling the Firm's technology net zero heat solution.
15138671 Canada Inc. × National Research Council Canada
9 grants totalling $3.2M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |